ORIGINAL INVESTIGATION

Transcription

1 ORIGINAL INVESTIGATION Prediction of Coronary Artery Calcium in Young Adults Using the Pathobiological Determinants of Atherosclerosis in Youth (PDAY) Risk Score The CARDIA Study Samuel S. Gidding, MD; C. Alex McMahan, PhD; Henry C. McGill, MD; Laura A. Colangelo, MS; Pamela J. Schreiner, PhD; O. Dale Williams, PhD; Kiang Liu, PhD Background: Using data from autopsied young people aged 15 to 34 years, the Pathobiological Determinants of Atherosclerosis in Youth (PDAY) study developed a risk score based on age, sex, smoking status, highdensity lipoprotein and non high-density lipoprotein cholesterol levels, and the presence of obesity, hyperglycemia, and hypertension to predict advanced coronary artery atherosclerosis. Methods: The Coronary Artery Risk Development in Young Adults (CARDIA) study assessed coronary artery calcium (CAC) by computed tomography in young adults participating in the 15-year examination. The PDAY risk score was calculated from risk factors measured at the CARDIA examinations at years 0, 5, 10, and 15. Results: Odds ratios for amount of CAC (6 ordinal categories) for a 1-point increase in risk score computed from the modifiable risk factors ranged from 1.10 to 1.16 (all statistically significant). Odds ratios for presence of any amount of CAC ranged from 1.09 to 1.15 (all statistically significant), with the highest odds ratio for the risk score at year 0. An increase in risk score between years 0 and 15 increased the odds of CAC, and a decrease in risk score decreased the odds of CAC. A positive family history of cardiovascular disease increased the odds of CAC. The c statistics ranged from to 0.770, with the highest discrimination based on the year 0 revised PDAY risk score that included family history and increased the points for the sex differential. Conclusion: The PDAY risk score predicts CAC up to 15 years before its assessment, and risk score change during 15 years affects the risk of CAC. Arch Intern Med. 2006;166: Author Affiliations: Alfred I. dupont Hospital for Children, Wilmington, Del, and Department of Pediatrics, Jefferson Medical College, Philadelphia, Pa (Dr Gidding); Department of Pathology, The University of Texas Health Science Center at San Antonio (Drs McMahan and McGill), and Southwest Foundation for Biomedical Research, San Antonio (Dr McGill); Department of Preventive Medicine, Feinberg School of Medicine, Northwestern University, Chicago, Ill (Ms Colangelo and Dr Liu); Division of Epidemiology and Community Health, University of Minnesota, Minneapolis (Dr Schreiner); and Division of Preventive Medicine, University of Alabama at Birmingham (Dr Williams). CARDIOVASCULAR EVENTS IN adulthood are linked to atherosclerosis, a process that begins in youth and is accelerated by the presence of risk factors, including dyslipidemia, hypertension, obesity, smoking, and diabetes mellitus. 1-8 Preventive efforts directed at young individuals range from encouraging healthy lifestyle behaviors that prevent cardiovascular risk factors (primordial prevention) to more aggressive behavioral and pharmacologic treatment of highrisk individuals (primary prevention). 9 Recent developments in imaging allow the noninvasive assessment of advanced atherosclerosis before the occurrence of clinical events These techniques have usually been applied to older individuals to enhance risk prediction, and their findings may influence clinical management in those with intermediate risk The techniques have also been used to detect atherosclerosis in high-risk young individuals, 10 to determine the relationship of risk factors in youth to the progression of atherosclerosis in young adulthood, 12,13 and to evaluate early pharmacologic treatment of familial hypercholesterolemia. 18 In persons aged 15 to 34 years who died of external causes (accidents, homicides, and suicides), the Pathobiological Determinants of Atherosclerosis in Youth (PDAY) study identified the association of atherosclerosis with cardiovascular risk factors measured postmortem. 2-4,6,7 A PDAY risk score, based on age, sex, and the cardiovascular risk factors, was developed to estimate the likelihood of advanced atherosclerosis in the coronary arteries of an individual. 19 The Coronary Artery Risk Development in Young Adults (CARDIA) study performed computed tomographic (CT) imaging of coronary artery calcium (CAC) in its year 15 examination (when participants were aged years). We used risk factor data from multiple prior examinations to determine how well the PDAY risk score computed from risk factors mea- 2341

2 Table 1. Pathobiological Determinants of Atherosclerosis in Youth (PDAY) Risk Score PDAY Risk Score Risk Factor Point Value Sex Male 0 Female 1 Age, y Non-HDL cholesterol level, mg/dl HDL cholesterol level, mg/dl Hyperglycemia Hyperglycemic 5 Normoglycemic 0 Hypertension Hypertensive 4 Normotensive 0 Smoking Smoker 1 Nonsmoker 0 Obesity Male, BMI 30 6 Male, BMI 30 0 Female 0 Abbreviations: BMI, body mass index (calculated as weight in kilograms divided by height in meters squared); HDL, high-density lipoprotein. SI conversion factor: To convert cholesterol to millimoles per liter, multiply by sured in youth predicted CAC measured years later in CARDIA subjects, and we estimated the effect of change in the PDAY risk score over time on its prediction of future CAC. We also revised the risk score by incorporating family history (information unavailable in the PDAY study) and compared the PDAY risk score prediction with that of the Framingham risk score. 8 METHODS PDAY RISK SCORE The PDAY risk score was derived from the associations of cardiovascular risk factors measured postmortem with target atherosclerotic lesions in the coronary arteries of 1117 cases. 19 The target lesions were American Heart Association grade IV or V lesions in the left anterior descending coronary artery, 6,20 greater than 9% of the intimal surface area of the right coronary artery involved with gross raised lesions, or both. Risk factors included high-density lipoprotein (HDL) and non-hdl cholesterol levels and thiocyanate concentration (as a marker of smoking) in postmortem serum, 3 body mass index (calculated as weight in kilograms divided by height in meters squared) at autopsy of at least 30 to define obesity, 7 hyperglycemia assessed by a red blood cell glycohemoglobin of at least 8%, 2 and hypertension assessed by the intimal thickness of the small renal arteries. 4 Risk factors and their point values are given in Table 1. Race/ethnicity was not a significant predictor of risk. The risk score was normalized so that a 1-point increase was equivalent to a multiplicative change in the odds (additive change in the logarithm of the odds) of a target lesion due to a 1-year increase in age. CARDIA STUDY The CARDIA study is a longitudinal study of cardiovascular risk factors begun in that included 5115 men and women from 4 centers (Birmingham, Ala; Chicago, Ill; Minneapolis, Minn; and Oakland, Calif). 20 The sample was population based and was approximately equally divided by sex, race/ ethnicity (African American vs white), and education level (completed vs did not complete high school). At its year 15 examination, CT scanning was performed on 3043 participants. The present study used risk scores calculated from the examinations at years 0, 5, 10, and 15. Participants were excluded if they (1) did not attend the examination, (2) were pregnant at the examination, or (3) were missing data needed for completion of the PDAY risk score or the Framingham risk score. 8 At the year 0 examination, the CARDIA cohort included participants younger than 20 years, for whom the Framingham risk score could not be computed. Therefore, the sample sizes were 2967 for the PDAY risk score and 2719 for the Framingham risk score at year 0, and they were 2769, 2732, and 2975 at years 5, 10, and 15, respectively, for the PDAY and Framingham risk scores. The CARDIA study was approved by the institutional review boards of all participating centers. RISK FACTOR MEASUREMENTS Age, sex, race/ethnicity, and smoking status were determined by self-report. Body mass index was calculated from weight and height measured in light clothing and without shoes. Blood pressure was measured 3 times by random zero sphygmomanometer, and the mean of the second and third measurements was used. Hypertension was defined as having a systolic blood pressure of at least 130 mm Hg or a diastolic blood pressure of at least 85 mm Hg or taking antihypertensive medications. Total cholesterol and HDL cholesterol levels were measured by enzymatic techniques, and non-hdl cholesterol levels were calculated by subtraction. 21 Diabetes mellitus was defined as having a fasting glucose level of at least 126 mg/dl ( 3.26 mmol/l); taking diabetic medication at the examinations at years 0, 10, and 15 (fasting glucose levels were unavailable at year 5); or both. Family history of cardiovascular disease was defined as having a parent with a cardiovascular event. Because family history was not updated at year 15, the year 10 family history was used. MEASUREMENT OF CAC Participants underwent CT scanning with electron beam CT (Imatron C-150) or multidetector CT (GE Lightspeed or Siemens VZ), depending on clinic location. All participants had 2 scans performed 1 to 2 minutes apart. For each scan, 40 consecutive 3-mm transverse images from the root of the aorta to the apex of the heart were obtained at 80% of the electrocardiographic R-R interval. Each image was examined by a radiologic technologist, who removed bony structures from the images and identified a region of interest around each potential focus of CAC. A focus was defined as a region of 4 adjacent pixels or more (approximately 1.87 mm 2 ) with a CT number higher than 130 Hounsfield units. Quantification of lesions of 2342

3 Table 2. Characteristics of the Coronary Artery Risk Development in Young Adults (CARDIA) Cohort for Whom Coronary Artery Calcium Scores Were Available at Year 15 Examination Year Men Women Risk Factor (n = 1358) (n = 1285) (n = 1261) (n = 1365) (n = 1609) (n = 1484) (n = 1471) (n = 1610) White race/ethnicity, % Age, mean ± SD, y 25.1 ± ± ± ± ± ± ± ± 3.6 Non-HDL cholesterol level, ± ± ± ± ± ± ± ± 32.7 mean ± SD, mg/dl HDL cholesterol level, 50.1 ± ± ± ± ± ± ± ± 14.2 mean ± SD, mg/dl Smokers, % Diabetes mellitus, % Body mass index,* mean ± SD 24.3 ± ± ± ± ± ± ± ± 7.2 Hypertensive, % Positive family history, % Risk score, median (minimum to maximum) PDAY 2 ( 1 to 19) 2 ( 1 to 18) 3 ( 1 to 24) 5 ( 1 to 25) 0 ( 2 to 18) 1 ( 2 to 18) 0 ( 2 to 18) 0 ( 2 to 17) Framingham 3 ( 10 to 11) 3 ( 10 to 17) 1 ( 10 to 22) 5 ( 10 to 26) 2 ( 8 to 28) 2 ( 8 to 24) 1 ( 8 to 31) 5 ( 8 to 25) Abbreviations: HDL, high-density lipoprotein; PDAY, Pathobiological Determinants of Atherosclerosis in Youth. SI conversion factor: To convert cholesterol to millimoles per liter, multiply by *Calculated as weight in kilograms divided by height in meters squared. this size is reproducible. 22 A total CAC score was computed as the sum of the Agatston score of calcified lesions within each artery (left main, left circumflex, left anterior descending, and right) and across all arteries. Coronary artery calcium was defined as present if each score was greater than 0; the mean of the 2 scans was the final score. Each scan set with at least 1 nonzero score was reviewed by an expert investigator blinded to the scan scores to verify the presence of CAC. The CAC scores were adjusted for between-center differences using a standard calcium phantom scanned underneath each participant. The amount of CAC was categorized into 6 categories (0, 0to 10, 10 to 20, 20 to 100, 100 to 400, or 400 units). 23 STATISTICAL ANALYSIS The association of CAC with risk score was analyzed using binary logistic regression, with the presence of any amount of CAC as the outcome and the predictor variables of sex, age at CAC assessment, and PDAY risk score computed from the modifiable risk factors. The amount of CAC was analyzed by ordinal logistic regression. 24,25 The association between CAC category and quartile of PDAY risk score at year 0 was assessed using the Goodman and Kruskal statistic. 25 Tracking was measured by the extent to which individuals in the lowest or highest quartiles for the PDAY risk score at year 0 remained in the same quartiles at year 15. The year 0 and year 15 PDAY risk scores computed from the modifiable risk factors were divided into examination-specific approximate quartiles for each sex group and race/ethnicity. The examination-specific quartiles were cross-tabulated to determine the percentage of those in a given quartile at year 0 who were in each quartile at year 15. If no tracking occurred, those in the highest (or lowest) quartile at year 0 were expected to be evenly distributed across quartiles at year 15. Quartiles are only approximately 25% of the sample. Heavy ties among PDAY risk scores precluded quartiles from having equal sample sizes. Based on their PDAY risk score computed from modifiable risk factors, participants were classified into low-risk, intermediate-risk, and high-risk groups. The cutoff points were selected so that the low-risk and high-risk groups would have at least the lowest and highest 25% of the year 0 PDAY risk scores, respectively. Within each of these 3 groups, participants were categorized into approximate thirds of the 15-year change (year 15 minus year 0) in the PDAY risk score to examine the effect of changing the modifiable risk factors. A revised PDAY risk score included points for family history of cardiovascular disease and increased the points for the sex differential. Points for family history were determined by dividing the logistic regression coefficient for family history by the coefficient for the PDAY risk score and by rounding to the nearest integer. The points for sex were determined in a similar manner. To validate the allocation of risk score points among sex, age at the time of risk factor measurement, modifiable risk factors, and family history, we computed c statistics 24 (equivalent to area under the receiver operating characteristic curve) to assess discrimination (ie, the ability to separate individuals with and without CAC); statistical significance among receiver operating characteristic curves at each visit was assessed. 26 At years 5, 10, and 15, the CARDIA study included participants older than 34 years. For these examinations, the age at the time of risk factor measurement was included as a predictor in the logistic regression model along with the PDAY risk score computed from the other risk factors. RESULTS CHARACTERISTICS OF THE CARDIA COHORT Table 2 gives descriptive statistics for the CARDIA cohort at each examination. For comparison between PDAY and Framingham risk scores, the age term was excluded. Over the 4 examinations, smoking frequency decreased, body mass index increased, non-hdl cholesterol levels trended upward, HDL cholesterol levels 2343

4 declined between years 5 and 10, prevalence of hypertension increased, prevalence of diabetes mellitus increased at year 10, and prevalence of positive family history increased through year 10. Year 15 CAC scores greater than 0 occurred in 201 (14.8%) of 1358 men and in 80 (5.0%) of 1609 women; the mean, median, minimum, and maximum CAC scores greater than 0 were 81.8, 21.8, 0.8, and , respectively. RELATIVE RISK DUE TO MODIFIABLE RISK FACTORS Table 3. Odds Ratios for Presence of Any Amount of Coronary Artery Calcium (CAC) and for Amount of CAC at Year 15 Examination Year Odds Ratio (95% Confidence Interval) Presence of Any Amount of CAC Amount of CAC ( ) 1.16 ( ) ( ) 1.15 ( ) ( ) 1.12 ( ) ( ) 1.10 ( ) Table 3 gives the odds ratios (ORs) for the presence of any amount of CAC at year 15 and for the amount of CAC for a 1-point increase in PDAY risk scores computed from the modifiable risk factors at each of the 4 examinations, adjusted for sex and age at measurement of CAC. All ORs were significantly different from Accounting for the amount of CAC increased the ORs at each examination by 0.01 compared with the ORs for the presence of CAC. Table 4 gives the relationship between the amount of CAC and the PDAY risk score computed from modifiable risk factors; this relationship was positive and significant ( =0.51 [95% confidence interval, ]). Of those with CAC scores greater than 100, 33 (71.7%) of 46 had PDAY risk scores of at least 3. PERSISTENCE OF RISK As summarized in Table 5, the PDAY risk score tracked well. About 50% (minimum 37% and maximum 57%) of young people in the first or fourth quartile of risk at year 0 remained within that quartile at year 15. EFFECT OF CHANGING THE MODIFIABLE RISK FACTORS Figure 1 shows the effect of risk score change on the odds of CAC in subjects at 3 levels of risk score computed from the modifiable risk factors at year 0 (lowest, 1 or 0; intermediate, 1-2; and highest, 3). The reference category (OR, 1.00) is the lowest year 0 risk and lowest change group. In the lowest risk group at year 0, for those whose risk score increased the most, the likelihood of CAC increased, but the OR was not statistically significant. Subjects with intermediate risk at year 0 that changed little or increased were significantly more likely to develop CAC than the low-risk and lowchange group; the subjects who decreased their score were not significantly different from the reference group. Subjects with the highest risk at year 0 were significantly more likely to develop CAC than the low-risk and lowchange group regardless of their risk score change. The Table 4. Pathobiological Determinants of Atherosclerosis in Youth (PDAY) Risk Scores Computed From the Modifiable Risk Factors at Year 0, by Coronary Artery Calcium (CAC) Category at Year 15* PDAY Risk Score CAC Category Quartile Score 0 0 to to to to Total (98.5) 2 (0.5) 1 (0.2) 3 (0.7) (95.0) 15 (1.7) 7 (0.8) 14 (1.6) 8 (0.9) to (90.4) 29 (3.5) 14 (1.7) 33 (3.9) 4 (0.5) 1 (0.1) to (82.0) 43 (5.1) 23 (2.8) 51 (6.1) 26 (3.1) 7 (0.8) 835 Total 1 to *Unless otherwise indicated, data are given as number (percentage) among participants of the Coronary Artery Risk Development in Young Adults (CARDIA) study. Table 5. Spearman Rank Correlation Coefficients Between Pathobiological Determinants of Atherosclerosis in Youth (PDAY) Risk Scores at Year 0 and at Year 15 Race/Ethnicity Spearman Rank Correlation Coefficient % (95% CI) in Quartile 1 at Year 0 and at Year 15 Expected % in Quartile 1 at Year 15* % (95% CI) in Quartile 4 at Year 0 and at Year 15 Expected % in Quartile 4 at Year 15* African American Male (31-44) (44-60) 25 Female (46-64) (47-62) 28 White Male (39-52) (49-65) 25 Female (37-53) (36-49) 23 Abbreviation: CI, confidence interval. *Expected percentage under null hypothesis of no tracking. 2344

5 Year 0 to Year 15 Change Lowest Middle Highest Table 6. Odds Ratios for Predicting Coronary Artery Calcium at Year 15 From the Pathobiological Determinants of Atherosclerosis in Youth (PDAY) Risk Score Computed From the Modifiable Risk Factors vs From a Family History of Cardiovascular Disease Odds Ratio Lowest Intermediate PDAY Risk Score Highest Examination Year Odds Ratio (95% Confidence Interval) PDAY Risk Score Computed From the Modifiable Risk Factors Family History ( ) 1.81 ( ) ( ) 1.66 ( ) ( ) 1.59 ( ) ( ) 1.66 ( ) Figure 1. Odds ratios for the likelihood of having coronary artery calcium at the year 15 examination by the Pathobiological Determinants of Atherosclerosis in Youth (PDAY) risk score computed from the modifiable risk factors at year 0 and by the change in PDAY risk score from year 0 to year 15 within each of the risk groups. The reference category is the group with the lowest baseline risk and the lowest change. intermediate and highest subjects at year 0 who decreased their risk score experienced a decreased OR relative to the subjects who remained the same or increased their risk score slightly. CONTRIBUTION OF FAMILY HISTORY Table 6 gives the ORs for a positive family history of cardiovascular disease (all ORs were significantly different from 1.00). The ORs for the PDAY risk score computed from the modifiable risk factors were only slightly different from the ORs estimated in a model without family history (Table 3). REVISED PDAY RISK SCORE A revised PDAY risk score was constructed using 8 points for female sex and 4 points for positive family history of cardiovascular disease. The PDAY risk score points (Table 1) were used for the modifiable risk factors. PREDICTION OF CAC USING THE PDAY RISK SCORE The foregoing analyses showed that the PDAY risk score computed from the modifiable risk factors identified a risk of CAC years in advance of CAC assessment. Table 7 gives c statistics for the risk score, including age and sex at the 4 examinations. The c statistics ranged from to and represented acceptable discrimination. 24 COMPARISON OF PDAY, REVISED PDAY, AND FRAMINGHAM RISK SCORES The revised PDAY risk score performed better than the original PDAY risk score, with c statistics ranging from to (Table 7). The highest c statistics were obtained for risk scores computed from the year 0 and year 5 examinations. The Framingham risk score performed less well, with c statistics below 0.7. At each examination, the c statistics among the 3 risk scores were significantly different. Figure 2 shows the receiver operating characteristic curves for predicting CAC at year 15 using the PDAY risk score, the revised PDAY risk score, and the Framingham risk score at year 0. COMMENT This study links a cardiovascular risk score based on anatomically demonstrated atherosclerosis in autopsied subjects 19 and the noninvasive assessment of CAC by CT scanning in living subjects from the CARDIA study. Young people with modifiable risk factors were at increased risk of developing CAC, and this increased risk was detected up to 15 years before the measurement of CAC. The risk score computed from risk factors measured 10 to 15 years before the assessment of CAC performed better than the risk score computed from risk factors at the time of CAC assessment. If the risk score increased between year 0 and year 15, the likelihood of developing CAC increased; if the risk score decreased, the likelihood of developing CAC decreased. The PDAY risk score and a revised PDAY risk score that included family history of cardiovascular disease and a greater differential between the sexes performed better than the Framingham risk score. COMPARISON WITH OTHER STUDIES Our findings are similar to those of other studies showing the association of risk factors measured in youth with CAC 27 and carotid intimal thickness 12,13 measured later in life. Our results also are consistent with the tracking of individual risk factors. 28,29 PREDICTION OF CAC For years 0 and 5, the ORs for a 1-point increase in the PDAY risk score (Table 3) were similar to the OR of 1.18 obtained in the PDAY sample used for risk score development. 19 Discrimination of the PDAY risk score (c statistic range, ; Table 7) validates the PDAY risk score model. 2345

6 Table 7. c Statistics for Predicting Coronary Artery Calcium at Year 15 c Statistic (95% Confidence Interval) Examination Year PDAY Risk Score Revised PDAY Risk Score Framingham Risk Score ( ) ( ) ( ) ( ) ( ) ( ) ( ) ( ) ( ) ( ) ( ) ( ) Abbreviation: PDAY, Pathobiological Determinants of Atherosclerosis in Youth. Sensitivity PDAY (c = 0.736) Revised PDAY (c = 0.770) Framingham (c = 0.619) Specificity Figure 2. Receiver operating characteristic curves for the prediction of coronary artery calcium among Coronary Artery Risk Development in Young Adults (CARDIA) subjects at year 15 using the Pathobiological Determinants of Atherosclerosis in Youth (PDAY) risk score, revised PDAY risk score, and Framingham risk score at year 0. Incorporation of family history of cardiovascular disease and a larger differential for sex than in the original PDAY risk score improved prediction. The highest discrimination and ORs were obtained for the revised PDAY risk score at the year 0 examination (c statistic, 0.770; Table 7), although this discrimination was not appreciably better than the discrimination at other visits. Coronary artery calcium may vary by race/ethnicity, 30 but we did not adjust for this factor because race/ethnicity was not a significant predictor of advanced atherosclerosis in the PDAY sample. 19 Additional refinements using risk factors not measured in the PDAY study may improve prediction; for example, a recent CARDIA publication reported an inverse association between CAC and education level. 23 Discrimination of the PDAY risk score was higher than discrimination of the Framingham risk score in predicting CAC in young adults. The Framingham risk score was developed from predominantly middle-aged and older individuals (different from the CARDIA cohort) to predict cardiovascular events that result from atherosclerosis and thrombosis. 8 The Framingham risk score is useful but imperfect for identifying middle-aged and older adults at risk for cardiovascular events; the PDAY risk score is useful but imperfect for identifying young persons likely to have precocious atherosclerosis EARLY CONTROL OF RISK FACTORS The objective of beginning cardiovascular risk prevention in youth is to retard the early progression of atherosclerosis. This study shows the effect of risk acquired early in life and the importance of risk reduction in young adulthood to prevent atherosclerosis. For most individuals, behavioral intervention to maintain cardiovascular health includes not smoking, maintaining normal weight for height, engaging in regular exercise, and consuming a proper diet. 9 Among subjects in the Atherosclerosis Risk in Communities study, 31 individuals with a sequence variation in PCSK9 had 28% (among African American subjects) and 15% (among white subjects) reductions in low-density lipoprotein cholesterol levels, with 88% (among African American subjects) and 47% (among white subjects) reductions in risk of CHD. This result supports the benefit of even modest reduction in risk factors during a long period. The PDAY risk score will be helpful in identifying subjects who should undergo imaging studies and those most likely to have rapid progression of atherosclerosis. Imaging can stratify individuals who are at high risk based on the risk factors into those with and without premature atherosclerosis and can assess the rate of progression of atherosclerosis over time with and without intervention. 18,32 Because event rates at young ages are low, it is difficult to conduct clinical trials to show that risk reduction reduces event rates. 17 Noninvasive imaging of atherosclerosis will facilitate studies of behavioral and pharmacologic risk factor intervention in adolescents and young adults. 32 Results from such studies will provide the gold standard of evidence regarding the value of cardiovascular risk factor control in youth. CONCLUSIONS The following findings support that primordial and primary prevention prevents or delays CHD: (1) Risk scores computed from the CHD risk factors in young people are strongly associated with CAC 10 to 15 years later. (2) Risk scores track. (3) An increase in risk score over time increases the likelihood of CAC. (4) A decrease in risk score over time decreases the risk of CAC. Accepted for Publication: August 15, Correspondence: Samuel S. Gidding, MD, Alfred I. dupont Hospital for Children, 1600 Rockland Rd, Wilmington, DE (sgidding@nemours.org). 2346

7 Author Contributions: Study concept and design: Gidding, McMahan, and Williams. Acquisition of data: Gidding and Schreiner. Analysis and interpretation of data: Gidding, McMahan, McGill, Colangelo, Williams, and Liu. Drafting of the manuscript: Gidding, McMahan, and McGill. Critical revision of the manuscript for important intellectual content: Gidding, McMahan, McGill, Colangelo, Schreiner, Williams, and Liu. Statistical analysis: Gidding, McMahan, Colangelo, Schreiner, Williams, and Liu. Obtained funding: Schreiner. Administrative, technical, and material support: Gidding. Study supervision: Gidding. Financial Disclosure: None reported. Funding/Support: The CARDIA study is supported by grants N01-HC-48048, N01-HC-48049, N01-HC , and N01-HC from the National Heart, Lung, and Blood Institute. Dr Gidding was supported in part by grant 1 P20 RR from the National Center for Research Resources. REFERENCES 1. Strong JP, Malcom GT, McMahan CA, et al. Prevalence and extent of atherosclerosis in adolescents and young adults: implications for prevention from the Pathobiological Determinants of Atherosclerosis in Youth Study. JAMA. 1999; 281: McGill HC Jr, McMahan CA, Malcom GT, Oalmann MC, Strong JP; Pathobiological Determinants of Atherosclerosis in Youth (PDAY) Research Group. Relation of glycohemoglobin and adiposity to atherosclerosis in youth. Arterioscler Thromb Vasc Biol. 1995;15: McGill HC Jr, McMahan CA, Malcom GT, Oalmann MC, Strong JP; PDAY Research Group. Effects of serum lipoproteins and smoking on atherosclerosis in young men and women. Arterioscler Thromb Vasc Biol. 1997;17: McGill HC Jr, McMahan CA, Tracy RE, et al. Relation of a postmortem renal index of hypertension to atherosclerosis and coronary artery size in young men and women. Arterioscler Thromb Vasc Biol. 1998;18: Berenson GS, Srinivasan SR, Bao W, et al. Association between multiple cardiovascular risk factors and atherosclerosis in children and young adults: the Bogalusa Heart Study. N Engl J Med. 1998;338: McGill HC Jr, McMahan CA, Zieske AW, et al. Association of coronary heart disease risk factors with microscopic qualities of coronary atherosclerosis in youth. Circulation. 2000;102: McGill HC Jr, McMahan CA, Herderick EE, et al. Obesity accelerates the progression of coronary atherosclerosis in young men. Circulation. 2002;105: National Cholesterol Education Program. Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) final report. Circulation. 2002;106: Williams CL, Hayman LL, Daniels SR, et al. Cardiovascular health in childhood: a statement for health professionals from the Committee on Atherosclerosis, Hypertension, and Obesity in the Young (AHOY) of the Council on Cardiovascular Disease in the Young, American Heart Association [published correction appears in Circulation. 2002;106:1178]. Circulation. 2002;106: Gidding SS, Bookstein LC, Chomka EV. Usefulness of electron beam tomography in adolescents and young adults with heterozygous familial hypercholesterolemia. Circulation. 1998;98: Fayad ZA, Fuster V, Nikolaou K, Becker C. Computed tomography and magnetic resonance imaging for noninvasive coronary angiography and plaque imaging: current and potential future concepts. Circulation. 2002;106: Li S, Chen W, Srinivasan SR, et al. Childhood cardiovascular risk factors and carotid vascular changes in adulthood: the Bogalusa Heart Study. JAMA. 2003; 290: Raitakari OT, Juonala M, Kahonen M, et al. Cardiovascular risk factors in childhood as predictors of carotid artery intima-media thickness in adulthood: the Cardiovascular Risk in Young Finns Study. JAMA. 2003;290: Greenland P, LaBree L, Azen SP, Doherty TM, Detrano RC. Coronary artery calcium score combined with Framingham score for risk prediction in asymptomatic individuals. JAMA. 2004;291: Mozaffarian D. Electron-beam computed tomography for coronary calcium: a useful test to screen for coronary heart disease? JAMA. 2005;294: Arad Y, Goodman KJ, Roth M, Newstein D, Guerci AD. Coronary calcification, coronary disease risk factors, C-reactive protein, and atherosclerotic cardiovascular disease events: the St. Francis Heart Study. J Am Coll Cardiol. 2005;46: Taylor AJ, Bindeman J, Feuerstein I, Cao F, Brazaitis M, O Malley PG. Coronary calcium independently predicts incident premature coronary heart disease over measured cardiovascular risk factors: mean three-year outcomes in the Prospective Army Coronary Calcium (PACC) project. J Am Coll Cardiol. 2005;46: Wiegman A, Hutten BA, de Groot E, et al. Efficacy and safety of statin therapy in children with familial hypercholesterolemia: a randomized controlled trial. JAMA. 2004;292: McMahan CA, Gidding SS, Fayad ZA, et al. Risk scores predict atherosclerotic lesions in young people. Arch Intern Med. 2005;165: Stary HC, Chandler AB, Dinsmore RE, et al. A definition of advanced types of atherosclerotic lesions and a histological classification of atherosclerosis: a report from the Committee on Vascular Lesions of the Council on Arteriosclerosis, American Heart Association. Arterioscler Thromb Vasc Biol. 1995;15: Friedman GD, Cutter GR, Donahue RP, et al. CARDIA: study design, recruitment, and some characteristics of the examined subjects. J Clin Epidemiol. 1988; 41: Agatston AS, Janowitz WR, Hildner FJ, Zusmer NR, Viamonte M Jr, Detrano R. Quantification of coronary artery calcium using ultrafast computed tomography. J Am Coll Cardiol. 1990;15: Yan LL, Liu K, Daviglus ML, et al. Education, 15-year risk factor progression, and coronary artery calcium in young adulthood and early middle age: the Coronary Artery Risk Development in Young Adults study. JAMA. 2006;295: Hosmer DW, Lemeshow S. Applied Logistic Regression. 2nd ed. New York, NY: John Wiley & Sons Inc; Agresti A. Categorical Data Analysis. 2nd ed. Hoboken, NJ: John Wiley & Sons Inc; DeLong ER, DeLong DM, Clarke-Pearson DL. Comparing the areas under two or more correlated receiver operating characteristic curves: a nonparametric approach. Biometrics. 1988;44: Mahoney LT, Burns TL, Stanford W, et al. Coronary risk factors measured in childhood and young adult life are associated with coronary artery calcification in young adults: the Muscatine Study. J Am Coll Cardiol. 1996;27: Clarke WR, Schrott HG, Leaverton PE, Connor WE, Lauer RM. Tracking of blood lipids and blood pressures in school age children: the Muscatine Study. Circulation. 1978;58: Webber LS, Cresanta JL, Voors AW, Berenson GS. Tracking of cardiovascular disease risk factor variables in school-age children. J Chronic Dis. 1983;36: Bild DE, Detrano R, Peterson D, et al. Ethnic differences in coronary calcification: the Multi-Ethnic Study of Atherosclerosis (MESA). Circulation. 2005;111: Cohen JC, Boerwinkle E, Mosley TH, Hobbs HH. Sequence variations in PCSK9, low LDL, and protection against coronary heart disease. N Engl J Med. 2006; 354: Gidding SS. The aging of the cardiovascular system: when should children be treated like adults? J Pediatr. 2002;141:

8 13. Beck AT, Beamesderfer A. Assessment of depression: the depression inventory. Modern Probl Pharmacopsychiatry. 1974;7: Beck AT, Steer RA. Beck Depression Inventory Manual. San Antonio, Tex: Psychological Corp; Davidson KW, Rieckman N, Lesperance F. Psychological theories of depression: potential application for the prevention of acute coronary syndrome recurrence. Psychosom Med. 2004;66: Frasure-Smith N, Lesperance F, Talajic M. Depression and 18-month prognosis after myocardial infarction [published correction appears in Circulation. 1998;97:708]. Circulation. 1995;91: Carney RM, Blumenthal JA, Catellier D, et al. Depression as a risk factor for mortality after acute myocardial infarction. Am J Cardiol. 2003;92: Joynt KE, Whellan DJ, O Connor CM. Depression and cardiovascular disease: mechanisms of interaction. Biol Psychiatry. 2003;54: Carney RM, Blumenthal JA, Stein PK, et al. Depression, heart rate variability, and acute myocardial infarction. Circulation. 2001;104: Watkins LL, Grossman P. Association of depressive symptoms with reduced baroreflex cardiac control in coronary artery disease. Am Heart J. 1999;137: Hughes JW, Watkins L, Blumenthal JA, Kuhn C, Sherwood A. Depression and anxiety symptoms are related to increased 24-hour urinary norepinephrine excretion among healthy middle-aged women. J Psychosom Res. 2004;57: von Kanel R, Mills PJ, Fainman C, Dimsdale JE. Effects of psychological stress and psychiatric disorders on blood coagulation and fibrinolysis: a biobehavioral pathway to coronary artery disease? Psychosom Med. 2001;63: Kop WJ, Gottdiener JS, Tangen CM, et al. Inflammation and coagulation factors in persons 65 years of age with symptoms of depression but without evidence of myocardial ischemia. Am J Cardiol. 2002;89: Sherwood A, Hinderliter AL, Watkins LL, Waugh RA, Blumenthal JA. Impaired endothelial function in coronary heart disease patients with depressive symptomatology. J Am Coll Cardiol. 2005;46: Gottlieb SS, Khatta M, Friedmann E, et al. The influence of age, gender, and race on the prevalence of depression in heart failure patients. J Am Coll Cardiol. 2004; 43: Carney RM, Blumenthal JA, Freedland KE, et al. Depression and late mortality after myocardial infarction in the Enhancing Recovery in Coronary Heart Disease (ENRICHD) study. Psychosom Med. 2004;66: Ray WA, Meredith S, Thapa PB, Hall K, Murray KT. Cyclic antidepressants and the risk of sudden cardiac death. Clin Pharmacol Ther. 2004;75: Correction Y-Axis Incorrectly Labeled in Figure 1. In the original investigation titled Prediction of Coronary Artery Calcium in Young Adults Using the Pathobiological Determinants of Atherosclerosis in Youth (PDAY) Risk Score: The CARDIA Study, by Gidding et al published in the November 27th issue of the ARCHIVES (2006;166: ), the y-axis in Figure 1 on page 2345 should have read from top to bottom as follows: 10, 8, 6, 4, and 2. (REPRINTED) ARCH INTERN MED/ VOL 167, FEB 26, American Medical Association. All rights reserved.